Rockville, MD : The American Society of Human Genetics (ASHG) is pleased to announce the appointment of Charles Lee, PhD, DSc, FACMG, FRSC, as the new Editor-in-Chief of Human Genetics and Genomics Advances (HGG Advances), ASHG’s fully open-access journal. Dr. Lee will serve a five-year term beginning on January 1, 2027.
“I’m honored to serve as Editor-in-Chief of HGG Advances,” said Dr. Lee “The journal plays a vital role in advancing innovative, high-quality science and ensuring that new discoveries in human genetics and genomics are accessible to the global community. I look forward to partnering with authors, reviewers, and the editorial team to publish the best work being done across the field.”
Since launching in May 2020, HGG Advances has provided a home for impactful research spanning the field of human genetics and genomics. Together with its sibling journal, The American Journal of Human Genetics (AJHG), HGG Advances is a leading venue for thought-provoking research and review. ASHG expresses deep gratitude to outgoing Editor-in-Chief Michael Bamshad, MD for his leadership in establishing HGG Advances as a platform that supports high-quality, rapid expansion of discovery in human genetics and genomics.
A Search Task Force of ASHG members led by Chris Gunter, PhD evaluated candidates based on scientific excellence and editorial experience.
“Dr. Lee brings an outstanding record of scientific leadership, volunteer commitment, and editorial experience to this role,” said ASHG President Susan A. Slaugenhaupt, PhD. “We are excited to welcome him as Editor-In-Chief and look forward to seeing him build on the strong foundation that Dr. Bamshad has established.”
Dr. Lee is the Robert Alvine Family Endowed Chair and a Professor at The Jackson Laboratory for Genomic Medicine, an institute he established and built into a world-class program advancing genomic medicine. At the end of June, Dr. Lee will join the University of Connecticut School of Medicine as Associate Dean of Translational Genomics and Professor of Genetics and Genome Science in the School of Medicine. Internationally recognized for discovering genome-wide copy-number variants (CNVs) in the human genome, he develops and applies cutting-edge methods to uncover how structural genomic variation shapes human biology, evolution, and disease. He co-leads global collaborative efforts to study the ‘hard-to-see’ parts of the genome. A highly cited scientist, he is also a Fellow of the American Association for the Advancement of Science (AAAS), the Korean Academy of Science and Technology (KAST), and the Royal Society of Canada (RSC). Dr. Lee is committed to accelerating rigorous, translational genomics to improve patient care.
|
|